Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
US10981906B2 · kind B2 · utility
6Cited by
8References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2018 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | Nov 2, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new pyrrolopyridine compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibition of JAK1 and JAK3 kinase activity in a human or animal subject are also provided for the treatment diseases such as pruritus, alopecia, androgenetic alopecia, alopecia areata, vitiligo and psoriasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.